Anixa Biosciences, Inc. (FRA:CY71)

Anixa Biosciences Statistics

Total Valuation

FRA:CY71 has a market cap or net worth of EUR 85.40 million. The enterprise value is 71.78 million.

Market Cap	85.40M
Enterprise Value	71.78M

Important Dates

The last earnings date was Friday, January 9, 2026.

Earnings Date	Jan 9, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	33.38M
Shares Outstanding	n/a
Shares Change (YoY)	+1.74%
Shares Change (QoQ)	+1.42%
Owned by Insiders (%)	5.41%
Owned by Institutions (%)	14.83%
Float	31.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	7.06
P/TBV Ratio	6.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.58
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.08, with a Debt / Equity ratio of 0.01.

Current Ratio	8.08
Quick Ratio	7.71
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -67.17% and return on invested capital (ROIC) is -43.96%.

Return on Equity (ROE)	-67.17%
Return on Assets (ROA)	-38.83%
Return on Invested Capital (ROIC)	-43.96%
Return on Capital Employed (ROCE)	-82.91%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-2.37M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.90%
50-Day Moving Average	3.22
200-Day Moving Average	2.91
Relative Strength Index (RSI)	41.49
Average Volume (20 Days)	1,837

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.69

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.14M
Pretax Income	-9.56M
Net Income	-9.47M
EBITDA	n/a
EBIT	-10.14M
Earnings Per Share (EPS)	-0.29

Balance Sheet

The company has 13.16 million in cash and 176,868 in debt, with a net cash position of 12.98 million.

Cash & Cash Equivalents	13.16M
Total Debt	176,868
Net Cash	12.98M
Net Cash Per Share	n/a
Equity (Book Value)	12.09M
Book Value Per Share	0.40
Working Capital	12.07M

Cash Flow

Operating Cash Flow	-6.22M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:CY71 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.74%
Shareholder Yield	-1.74%
Earnings Yield	-11.09%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1